Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Last Close
Dec 11 04:00PM ET
1.88
Dollar change
-0.10
Percentage change
-4.81
%
Index- P/E- EPS (ttm)-1.84 Insider Own31.67% Shs Outstand10.17M Perf Week-3.09%
Market Cap19.12M Forward P/E- EPS next Y-2.49 Insider Trans0.00% Shs Float6.95M Perf Month7.43%
Income-18.70M PEG- EPS next Q-0.56 Inst Own7.07% Short Float0.10% Perf Quarter11.90%
Sales0.00M P/S- EPS this Y-4.81% Inst Trans6.59% Short Ratio0.38 Perf Half Y-32.86%
Book/sh1.25 P/B1.51 EPS next Y-27.04% ROA-76.57% Short Interest0.01M Perf Year8.67%
Cash/sh1.29 P/C1.46 EPS next 5Y- ROE-86.20% 52W Range1.33 - 3.10 Perf YTD9.16%
Dividend Est.- P/FCF- EPS past 5Y-1.25% ROI-130.92% 52W High-39.35% Beta1.53
Dividend TTM- Quick Ratio7.32 Sales past 5Y-33.86% Gross Margin- 52W Low41.89% ATR (14)0.14
Dividend Ex-Date- Current Ratio7.32 EPS Y/Y TTM8.73% Oper. Margin- RSI (14)43.91 Volatility6.64% 8.12%
Employees12 Debt/Eq0.15 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price8.50
Option/ShortNo / Yes LT Debt/Eq0.12 EPS Q/Q-18.33% Payout- Rel Volume0.58 Prev Close1.98
Sales Surprise- EPS Surprise14.04% Sales Q/Q- EarningsNov 13 BMO Avg Volume18.48K Price1.88
SMA20-7.61% SMA50-2.13% SMA200-0.46% Trades Volume10,670 Change-4.81%
Date Action Analyst Rating Change Price Target Change
Jul-08-20Initiated H.C. Wainwright Buy $5
Nov-13-24 08:00AM
Oct-31-24 08:00AM
Sep-26-24 08:00AM
Aug-19-24 04:05PM
Aug-15-24 03:00PM
08:00AM Loading…
Aug-14-24 08:00AM
Jul-18-24 08:00AM
Jun-20-24 08:00AM
Jun-07-24 09:55AM
May-13-24 01:53PM
08:00AM
May-01-24 08:00AM
Mar-28-24 01:53PM
08:00AM
Mar-19-24 08:00AM
08:30AM Loading…
Mar-05-24 08:30AM
Jan-04-24 08:00AM
Dec-06-23 08:00AM
Nov-29-23 08:00AM
Nov-27-23 08:00AM
Nov-13-23 08:00AM
Nov-09-23 08:00AM
Oct-31-23 08:00AM
Oct-02-23 12:14PM
Sep-28-23 08:00AM
Sep-05-23 08:00AM
Aug-16-23 09:11AM
Aug-14-23 08:00AM
Aug-08-23 08:00AM
May-31-23 08:00AM
09:26AM Loading…
May-17-23 09:26AM
May-15-23 08:00AM
May-04-23 04:05PM
Apr-24-23 08:00AM
Apr-18-23 08:00AM
Apr-10-23 08:30AM
Mar-31-23 10:05AM
Mar-29-23 08:00AM
Mar-22-23 01:03PM
08:00AM
Jan-26-23 08:00AM
Jan-23-23 09:00AM
Dec-19-22 08:00AM
Dec-01-22 04:05PM
Nov-17-22 01:38PM
08:00AM
Nov-15-22 11:19AM
Nov-14-22 08:00AM
Nov-02-22 08:00AM
Nov-01-22 04:05PM
Oct-26-22 08:00AM
Oct-19-22 08:00AM
Oct-13-22 08:00AM
Oct-11-22 11:51AM
08:00AM
Oct-05-22 08:00AM
Oct-03-22 04:05PM
Sep-06-22 10:05AM
08:00AM
Aug-19-22 08:10AM
Aug-15-22 08:00AM
Aug-08-22 08:00AM
Aug-03-22 09:00AM
Jul-14-22 08:00AM
Jun-01-22 08:00AM
May-18-22 08:00AM
May-12-22 08:12AM
May-11-22 08:00AM
Apr-21-22 08:00AM
Apr-19-22 08:00AM
Apr-14-22 08:00AM
Apr-12-22 11:01AM
08:00AM
Apr-06-22 10:15AM
Mar-30-22 02:57PM
Mar-25-22 07:30AM
Mar-23-22 04:05PM
Mar-22-22 08:00AM
Mar-10-22 08:00AM
Mar-03-22 08:00AM
Feb-24-22 08:10AM
Jan-27-22 12:22PM
08:00AM
Jan-11-22 07:00AM
Jan-10-22 04:10PM
Jan-06-22 08:00AM
Jan-04-22 08:00AM
Dec-22-21 08:00AM
Dec-02-21 08:00AM
Dec-01-21 04:05PM
Nov-15-21 12:25PM
08:00AM
Nov-08-21 03:00PM
08:00AM
Nov-01-21 08:00AM
Oct-21-21 08:00AM
Oct-14-21 08:00AM
Oct-06-21 08:49AM
Oct-01-21 07:04AM
Sep-07-21 08:00AM
Cocrystal Pharma, Inc. is a biotechnology company, which engages in the discovery and development of novel antiviral therapeutics. It focuses on the preclinical and early clinical stage antiviral compounds for unmet medical needs including influenza, Hepatitis C virus, and norovirus infections. The company was founded in 2008 and is headquartered in Bothell, WA.